Arrowpoint Investment Partners »

United States Antimony shares owned by Arrowpoint Investment Partners

Quarter-by-quarter ownership of United States Antimony (UAMY) shares owned by Arrowpoint Investment Partners from 13F filings

Historical chart of Arrowpoint Investment Partners investment in United States Antimony

Tip: Access up to 7 years of quarterly data

All positions including United States Antimony held by Arrowpoint Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United States Antimony by Arrowpoint Investment Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $100k 11k 8.73

More positions owned by Arrowpoint Investment Partners

Ishares Tr Expanded Tech Call Option (IGV)
Kraneshares Trust Csi Chi Internet (KWEB)
Alphabet Cap Stk Cl A (GOOGL)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Ishares Msci Brazil Etf Call Option (EWZ)
Ase Technology Hldg Sponsored Ads (ASX)
Ionis Pharmaceuticals (IONS)
Neurocrine Biosciences (NBIX)
Axsome Therapeutics (AXSM)
BioMarin Pharmaceutical (BMRN)
Ascendis Pharma A/s Sponsored Adr (ASND)
Ptc Therapeutics I (PTCT)
Pfizer (PFE)
Regeneron Pharmaceuticals (REGN)
Johnson & Johnson (JNJ)

View all positions for Arrowpoint Investment Partners

Top funds holding United States Antimony

Van Eck Associates Corp.
BlackRock
State Street Corporation
Vanguard Group
Susquehanna International
Driehaus Capital Management
Vanguard Capital Management
Hood River Capital Management
Geode Capital Management
Citadel Advisors
Ameriprise Financial
UBS Group
Branch Banking & Trust Company
Jane Street
Ing Investment Management

View all funds holding United States Antimony